Stephen J. Schueler, M.D.

Overview Risk Factors Symptoms Evaluation Treatment questions for doctor Home Care pain and fever adults pain and fever children warning signs Prevention Outlook Complications Underlying Cause Anatomy

Bacterial Skin Infection Erysipelas Home Care

Home care for erysipelas includes:

Bacterial Skin Infection Erysipelas Pain and Fever Adults

Medications commonly used to control pain and fever in adults with erysipelas include:

  • Acetaminophen decreases fever and pain, but does not help inflammation.
  • Adult dosing is 2 regular strength (325 mg) every 4 hours or 2 extra-strength (500 mg) every 6 hours.
  • Maximum dose is 4,000 mg per day.
  • Avoid this drug if you have alcoholism, liver disease or an allergy to the drug. See the package instructions.
  • Common brand names include Tylenol, Panadol, and many others.





NSAID Precautions

Bacterial Skin Infection Erysipelas Pain and Fever Children

Common medications used at home for pain and fever in children with erysipelas include:

Aspirin and most of the other nonsteroidal anti-inflammatory drugs (NSAIDS) are not used in children except under a doctor's care.

  • Acetaminophen decreases fever and pain, but does not help inflammation.
  • Dosing is 10-15 mg per kilogram (5-7 mg per pound) of body weight every 4-6 hours, up to the adult dose.
  • Do not exceed the maximum daily dose.
  • Acetaminophen products come in various strengths. Always follow the package instructions.
  • Avoid this drug in children with liver disease or an allergy to acetaminophen.
  • Common acetaminophen products include Tylenol, Panadol and many others.



Bacterial Skin Infection Erysipelas Warning Signs

Continue to Bacterial Skin Infection Erysipelas Prevention

Last Updated: Feb 17, 2011 References
Authors: Stephen J. Schueler, MD; John H. Beckett, MD; D. Scott Gettings, MD
Copyright DSHI Systems, Inc. Powered by: FreeMD - Your Virtual Doctor

PubMed Bacterial Skin Infection Erysipelas References
  1. Bonnetblanc JM, Bedane C. Erysipelas: recognition and management. Am J Clin Dermatol. 2003;4(3):157-63. [12627991]
  2. Dupuy A, Benchikhi H, Roujeau JC, Bernard P, et al. Risk factors for erysipelas of the leg (cellulitis): case-control study. BMJ. 1999 Jun 12;318(7198):1591-4. [10364117]
  3. Roldan YB, Mata-Essayag S, Hartung C. Erysipelas and tinea pedis. Mycoses. 2000;43(5):181-3. [10948816]
FreeMD is provided for information purposes only and should not be used as a substitute for evaluation and treatment by a physician. Please review our terms of use.